Ahead of a New Jersey hearing on Thursday on a bill to legalize psilocybin and establish a system of licensed businesses to provide supervised access to the psychedelic, a new survey indicates that a majority of state residents agree with making it available for therapeutic use.

The poll, from Stockton University’s William J. Hughes Center for Public Policy, found that 55 percent of respondents support legalizing psilocybin for medical use with a under doctor’s supervision. Just 20 percent of respondents were opposed, while 24 percent said they weren’t sure. One percent of respondents refused to answer the question.

Younger residents—those between the ages of 18 and 49—as well as Democrats showed higher rates of support.

Despite the majority support for legalization of medical access, more respondents said they had a negative view generally of psychedelic drugs (32 percent) than a positive view (19 percent). Nearly half (47 percent) said they were neutral or had no opinion, and 2 percent weren’t sure.

In terms of personal use, 16 percent of respondents said they’d ever consumed psilocybin or other psychedelic drugs, like LSD or MDMA. Far more—82 percent—said they’d never tried psychedelics, and 2 percent refused the question.

About half (46 percent)

Read full article on Marijuana Moment